Skip to main content

Table 3 Cumulative incidence of adverse events among the two groups of patients during the nine-month follow-up

From: Optical coherence tomography: evaluating the effects of stent boost subtract imaging on stent underexpansion in STEMI patients

Adverse events

CAG group (N = 67)

SBS group (N = 68)

χ2 value

P value

MACE n (%)

9 (13.4)

2 (2.94)

4.964

0.026

AMI

2 (2.98)

0

  

TVR

4 (5.97)

1 (1.47)

  

AP

3 (4.47)

1 (1.47)

  
  1. MACE major adverse cardiac events, AMI acute myocardial infarction, TVR target vessel revascularization, AP angina pectoris, CAG coronary angiography, SBS stent boost subtract